Literature DB >> 32681647

Targeting metabolism to reverse T-cell exhaustion in chronic viral infections.

John D Sears1, Kevin J Waldron1, Jian Wei1, Chih-Hao Chang1,2,3.   

Abstract

CD8 T-cells are an essential component of the adaptive immune response accountable for the clearance of virus-infected cells via cytotoxic effector functions. Maintaining a specific metabolic profile is necessary for these T-cells to sustain their effector functions and clear pathogens. When CD8 T-cells are activated via T-cell receptor recognition of viral antigen, they transition from a naïve to an effector state and eventually to a memory phenotype, and their metabolic profiles shift as the cells differentiate to accomidate different metabolic demands. However, in the context of particular chronic viral infections (CVIs), CD8 T-cells can become metabolically dysfunctional in a state known as T-cell exhaustion. In this state, CD8 T-cells exhibit reduced effector functions and are unable to properly control pathogens. Clearing these chronic infections becomes progressively difficult as increasing numbers of the effector T-cells become exhausted. Hence, reversal of this dysfunctional metabolic phenotype is vital when considering potential treatments of these infections and offers the opportunity for novel strategies for the development of therapies against CVIs. In this review we explore research implicating alteration of the metabolic state as a means to reverse CD8 T-cell exhaustion in CVIs. These findings indicate that strategies targeting dysfunctional CD8 T-cell metabolism could prove to be a promising option for successfully treating CVIs.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  CD8; T-cell exhaustion; chronic viral infection; glycolysis; metabolism

Mesh:

Substances:

Year:  2020        PMID: 32681647      PMCID: PMC7808153          DOI: 10.1111/imm.13238

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  100 in total

1.  Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism.

Authors:  Marc O Johnson; Melissa M Wolf; Matthew Z Madden; Gabriela Andrejeva; Ayaka Sugiura; Diana C Contreras; Damian Maseda; Maria V Liberti; Katelyn Paz; Rigel J Kishton; Matthew E Johnson; Aguirre A de Cubas; Pingsheng Wu; Gongbo Li; Yongliang Zhang; Dawn C Newcomb; Andrew D Wells; Nicholas P Restifo; W Kimryn Rathmell; Jason W Locasale; Marco L Davila; Bruce R Blazar; Jeffrey C Rathmell
Journal:  Cell       Date:  2018-11-01       Impact factor: 41.582

2.  Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation.

Authors:  Tomonori Kato; Tetsuya Nishida; Yoshinori Ito; Miho Murase; Makoto Murata; Tomoki Naoe
Journal:  Cell Immunol       Date:  2014-03-11       Impact factor: 4.868

Review 3.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  Pembrolizumab for the treatment of non-small-cell lung cancer.

Authors:  Edward B Garon; Naiyer A Rizvi; Rina Hui; Natasha Leighl; Ani S Balmanoukian; Joseph Paul Eder; Amita Patnaik; Charu Aggarwal; Matthew Gubens; Leora Horn; Enric Carcereny; Myung-Ju Ahn; Enriqueta Felip; Jong-Seok Lee; Matthew D Hellmann; Omid Hamid; Jonathan W Goldman; Jean-Charles Soria; Marisa Dolled-Filhart; Ruth Z Rutledge; Jin Zhang; Jared K Lunceford; Reshma Rangwala; Gregory M Lubiniecki; Charlotte Roach; Kenneth Emancipator; Leena Gandhi
Journal:  N Engl J Med       Date:  2015-04-19       Impact factor: 91.245

5.  Posttranscriptional control of T cell effector function by aerobic glycolysis.

Authors:  Chih-Hao Chang; Jonathan D Curtis; Leonard B Maggi; Brandon Faubert; Alejandro V Villarino; David O'Sullivan; Stanley Ching-Cheng Huang; Gerritje J W van der Windt; Julianna Blagih; Jing Qiu; Jason D Weber; Edward J Pearce; Russell G Jones; Erika L Pearce
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

Review 6.  Modulation of dendritic cell function by persistent viruses.

Authors:  Bisheng Liu; Andrea M Woltman; Harry L A Janssen; Andre Boonstra
Journal:  J Leukoc Biol       Date:  2008-09-25       Impact factor: 4.962

7.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

8.  Leptin directly promotes T-cell glycolytic metabolism to drive effector T-cell differentiation in a mouse model of autoimmunity.

Authors:  Valerie A Gerriets; Keiko Danzaki; Rigel J Kishton; William Eisner; Amanda G Nichols; Donte C Saucillo; Mari L Shinohara; Nancie J MacIver
Journal:  Eur J Immunol       Date:  2016-06-13       Impact factor: 5.532

9.  Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.

Authors:  Heiner Wedemeyer; Xiao-Song He; Michelina Nascimbeni; Anthony R Davis; Harry B Greenberg; Jay H Hoofnagle; T Jake Liang; Harvey Alter; Barbara Rehermann
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

10.  TOX is a critical regulator of tumour-specific T cell differentiation.

Authors:  Andrew C Scott; Friederike Dündar; Paul Zumbo; Smita S Chandran; Christopher A Klebanoff; Mojdeh Shakiba; Prerak Trivedi; Laura Menocal; Heather Appleby; Steven Camara; Dmitriy Zamarin; Tyler Walther; Alexandra Snyder; Matthew R Femia; Elizabeth A Comen; Hannah Y Wen; Matthew D Hellmann; Niroshana Anandasabapathy; Yong Liu; Nasser K Altorki; Peter Lauer; Olivier Levy; Michael S Glickman; Jonathan Kaye; Doron Betel; Mary Philip; Andrea Schietinger
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

View more
  6 in total

1.  Sweet talk: Metabolic conversations between host and microbe during infection.

Authors:  Eyal Amiel; Georgia Perona-Wright
Journal:  Immunology       Date:  2021-02       Impact factor: 7.397

Review 2.  New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment.

Authors:  Ji-Yong Sung; Jae-Ho Cheong
Journal:  Cells       Date:  2022-02-22       Impact factor: 6.600

3.  Immune Checkpoint Molecules Expressed on CD4+ T Cell Subsets in Chronic Asymptomatic Hepatitis B Virus Carriers With Hepatitis B e Antigen-Negative.

Authors:  Dawei Cui; Daixi Jiang; Cuilin Yan; Xia Liu; Yan Lv; Jue Xie; Yu Chen
Journal:  Front Microbiol       Date:  2022-04-27       Impact factor: 5.640

Review 4.  The Role of Metabolic Dysfunction in T-Cell Exhaustion During Chronic Viral Infection.

Authors:  Kehong Zheng; Xiaojun Zheng; Wei Yang
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

5.  A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease.

Authors:  Ching-Tse Wu; Cheng-I Chu; Feng-Yu Wang; Hui-Yu Yang; Wei-Sung Tseng; Chuang-Rung Chang; Chien-Chung Chang
Journal:  Cell Biosci       Date:  2022-09-30       Impact factor: 9.584

Review 6.  The Role of Immune Cells in Recurrent Spontaneous Abortion.

Authors:  Dan Li; Lianwen Zheng; Donghai Zhao; Ying Xu; Yeling Wang
Journal:  Reprod Sci       Date:  2021-06-08       Impact factor: 3.060

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.